An investigation of the mechanisms of delayed neurodegeneration caused by direct injection of quinolinate into the rat striatum in vivo

作者: M.H.M. Barker , A.C. Foster

DOI: 10.1016/0306-4522(91)90383-Y

关键词:

摘要: Abstract Injection of the N -methyl- d -aspartate receptor agonist quinolinate, or itself, into rat brain produces neurodegeneration which can be prevented by antagonists administered up to 5 h after excitotoxin injection. The present study was designed investigate aspects mechanisms involved in this delayed form neurodegeneration. Following its injection striatum, extracellular levels [ 3 H]quinolinate were monitored using a microdialysis probe located 1 mm from site Peak concentrations observed 10–20 min and decayed biexponential fashion, initial component having an apparent t 1/2 13.7 ± 5.2 ( n = 3). Estimations quinolinate 200 nmol indicated peak level 6.0 mM 3) at declined 1.2 0.13 2 substantial h, period over are effective model. Administration dizocilpine 1, 2, 100, 400 resulted similar temporal profile neuroprotection, as assessed measuring activities choline acetyltransferase glutamate decar☐ylase striatal homogenates, independent degree produced different doses. Overall, these results suggest that neuronal degeneration caused vivo is critically dependent upon events occurring excitoxin space. (10 mg/kg i.p.) intrastriatal trans -2,3-piperidine dicar☐ylate (100 nmol) reduced neurotoxicity, whereas smaller effect against neurotoxicity ibotenate nmol), perhaps indicating action sites other than receptor. competitive antagonist, 3-[(±)-2-car☐ypiperazin-4-yl]-propyl-1-phosphonate, quinolinate-induced dose-dependent manner with approximate Ed 50 value 30 (i.p., quinolinate). Haloperidol (O.5mg/kg i.p.), diazepam (10mg/kg, ifenprodil (50mg/kg quinolate failed reduce degeneration, suggesting blockade dopamine receptors, enhancement GABA-mediated inhibition occupation sigma does not prevent agonist.

参考文章(58)
B Zivkovic, C Carter, E T MacKenzie, F Noel, P Legendre, J D Vincent, K G Lloyd, S Arbilla, J Benavides, F Thuret, Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. Journal of Pharmacology and Experimental Therapeutics. ,vol. 247, pp. 1222- 1232 ,(1988)
Jullien A, Carron C, Bucher B, Synthesis and pharmacological properties of a series of 2-piperidino alkanol derivatives. Drug Research. ,vol. 21, pp. 1992- ,(1971)
R S Sloviter, R C Collins, J W Olney, Excitotoxic mechanisms of epileptic brain damage. Advances in Neurology. ,vol. 44, pp. 857- 877 ,(1986)
Carl A. Boast, Susan C. Gerhardt, Gary Pastor, John Lehmann, Pierre E. Etienne, Jeffrey M. Liebman, The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils. Brain Research. ,vol. 442, pp. 345- 348 ,(1988) , 10.1016/0006-8993(88)91522-3
Samuel H. Wilson, Bruce K. Schrier, John L. Farber, Edward J. Thompson, Roger N. Rosenberg, Arthur J. Blume, Marshall W. Nirenberg, Markers for Gene Expression in Cultured Cells from the Nervous System Journal of Biological Chemistry. ,vol. 247, pp. 3159- 3169 ,(1972) , 10.1016/S0021-9258(19)45227-7
G. Garthwaite, J. Garthwaite, Quinolinate mimics neurotoxic actions of N-methyl-D-aspartate in rat cerebellar slices. Neuroscience Letters. ,vol. 79, pp. 35- 39 ,(1987) , 10.1016/0304-3940(87)90668-9
DT Monaghan, CW Cotman, Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain The Journal of Neuroscience. ,vol. 5, pp. 2909- 2919 ,(1985) , 10.1523/JNEUROSCI.05-11-02909.1985
D M Hartley, D W Choi, Delayed rescue of N-methyl-D-aspartate receptor-mediated neuronal injury in cortical culture. Journal of Pharmacology and Experimental Therapeutics. ,vol. 250, pp. 752- 758 ,(1989)